← boothcheck

EXPO vs STN stock comparison

EXPONENT, INC. vs STANTEC INC., two Consulting stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.

Two debt-free consultancies, and the resemblance ends at the balance sheet. Exponent runs a 24.9% operating margin on litigation-grade engineering analysis; Stantec runs single-digit net margins, 5.9%, on infrastructure design at scale. Returns on equity sit at 32.2% against 14.8%. The market prices them closer than the economics suggest, 28.4 and 22.4 times earnings, because Stantec offers what Exponent structurally cannot: a backlog that compounds with public-works spending. Stantec also converts more price into cash, an 8% free-cash yield against 3.7%. The choice is margin without scale or scale without margin, priced six turns apart.

Comparison updated 2026-07-10.

EXPO vs STN: the numbers

MetricEXPOSTN
Price$60.81$69.32
Market cap$3.0B$7.9B
SectorConsultingConsulting
StageMatureGrowth
Implied growth (priced in)+15.5%
P/E28.422.4
P/B9.013.32
P/S5.061.32
EV/EBITDA23.1
Revenue growth+7.8%+15.6%
Operating margin24.9%
Net margin18.1%5.9%
Return on equity32.2%14.8%
Return on assets15.8%6.0%
Return on invested capital24.1%
FCF yield3.7%8.0%
Dividend yield2.0%
Debt / equity0.000.00
Current ratio2.401.23
Altman Z (solvency)8.052.47
Piotroski F (quality)6 / 97 / 9
Full EXPO report → Full STN report →
Get boothcheck's read on EXPO and STN, and what their prices are betting on, in your inbox. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

Compare any two stocks

vs

The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.